Leap Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | 05/15/2023 | 7.43 M | $2.52 M | 1,226.69% | 5.74% |
PERCEPTIVE ADVISORS LLC | 05/16/2023 | 6.73 M | $2.29 M | 0.00% | 5.20% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2023 | 4.66 M | $1.58 M | 27.20% | 3.60% |
ARTAL GROUP S.A. | 05/12/2023 | 4.00 M | $1.36 M | 0.00% | 3.09% |
VANGUARD GROUP INC | 07/14/2023 | 3.21 M | $1.09 M | 0.00% | 2.48% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2023 | 2.80 M | $952,000 | 1.82% | 2.16% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2023 | 2.01 M | $684,141 | 151.52% | 1.56% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2023 | 1.54 M | $523,000 | 100.00% | 1.19% |
KEY CLIENT FIDUCIARY ADVISORS, LLC | 04/25/2023 | 1.54 M | $522,177 | 13.82% | 1.19% |
CORMORANT ASSET MANAGEMENT, LP | 05/15/2023 | 1.48 M | $504,000 | 100.00% | 1.15% |
UBS OCONNOR LLC | 05/15/2023 | 1.05 M | $356,553 | 100.00% | 0.81% |
CITADEL ADVISORS LLC | 05/15/2023 | 1.05 M | $341,499 | 142.64% | 0.81% |
SAMSARA BIOCAPITAL, LLC | 08/14/2023 | 846,038 | $287,653 | 100.00% | 0.65% |
BLACKROCK INC. | 05/12/2023 | 619,013 | $210,464 | 0.91% | 0.48% |
GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 618,673 | $210,348 | 0.00% | 0.48% |
KNOTT DAVID M JR | 05/11/2023 | 557,939 | $190,000 | -33.58% | 0.43% |
RENAISSANCE TECHNOLOGIES LLC | 05/12/2023 | 455,200 | $155,000 | -50.83% | 0.35% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2023 | 453,441 | $155,000 | 100.00% | 0.35% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2023 | 298,301 | $101,422 | 0.00% | 0.23% |
PLATINUM INVESTMENT MANAGEMENT LTD | 05/12/2023 | 264,413 | $89,900 | -80.09% | 0.20% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2023 | 183,895 | $62,524 | 1.08% | 0.14% |
STATE STREET CORP | 05/15/2023 | 177,739 | $60,431 | 0.00% | 0.14% |
NORTHERN TRUST CORP | 05/15/2023 | 152,931 | $51,997 | 20.84% | 0.12% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2023 | 50,700 | $17,238 | -4.52% | 0.04% |
MCADAM, LLC | 04/24/2023 | 45,778 | $15,565 | 39.64% | 0.04% |
ANNANDALE CAPITAL, LLC | 05/15/2023 | 40,000 | $14,000 | 0.00% | 0.03% |
TWO SIGMA INVESTMENTS, LP | 05/15/2023 | 39,790 | $13,529 | -59.43% | 0.03% |
BANK OF NEW YORK MELLON CORP | 05/09/2023 | 35,483 | $12,064 | 0.00% | 0.03% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/12/2023 | 32,000 | $10,880 | 0.00% | 0.02% |
RAYMOND JAMES & ASSOCIATES | 04/14/2023 | 29,678 | $10,091 | -11.88% | 0.02% |
TWO SIGMA ADVISERS, LP | 05/15/2023 | 27,400 | $9,316 | -90.73% | 0.02% |
LPL FINANCIAL LLC | 05/10/2023 | 26,375 | $8,968 | -4.52% | 0.02% |
JANNEY MONTGOMERY SCOTT LLC | 04/28/2023 | 25,000 | $8,000 | 0.00% | 0.02% |
CITADEL ADVISORS LLC | 05/15/2023 | 21,500 | $7,310 | -8.51% | 0.02% |
GROUP ONE TRADING, L.P. | 05/12/2023 | 21,240 | $7,222 | -18.75% | 0.02% |
ROCKEFELLER CAPITAL MANAGEMENT L.P. | 05/16/2023 | 17,000 | $5,000 | 100.00% | 0.01% |
CNB BANK | 05/10/2023 | 16,000 | $5,440 | 0.00% | 0.01% |
VALEO FINANCIAL ADVISORS, LLC | 04/17/2023 | 15,635 | $5,316 | 0.00% | 0.01% |
BAYSTATE WEALTH MANAGEMENT LLC | 04/25/2023 | 15,385 | $5,231 | 0.00% | 0.01% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 14,973 | $5,091 | -50.61% | 0.01% |
COMMUNITY TRUST & INVESTMENT CO | 04/18/2023 | 13,650 | $4,641 | 0.00% | 0.01% |
UBS GROUP AG | 05/12/2023 | 13,064 | $4,442 | 30.64% | 0.01% |
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 04/14/2023 | 12,878 | $4,379 | 100.00% | 0.01% |
MILLENNIUM MANAGEMENT LLC | 05/15/2023 | 12,670 | $4,000 | -98.85% | 0.01% |
D.A. DAVIDSON & CO. | 04/25/2023 | 11,000 | $3,740 | 100.00% | 0.01% |
MORGAN STANLEY | 05/15/2023 | 10,334 | $3,514 | 4.17% | 0.01% |
JANE STREET GROUP, LLC | 05/16/2023 | 10,008 | $3,403 | -94.48% | 0.01% |
DONALDSON CAPITAL MANAGEMENT, LLC | 04/13/2023 | 10,000 | $3,400 | 0.00% | 0.01% |
CAPTRUST FINANCIAL ADVISORS | 05/15/2023 | 10,000 | $3,400 | 100.00% | 0.01% |
US BANCORP \DE\ | 05/09/2023 | 6,100 | $2,074 | 0.00% | 0.00% |
Leap Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Leap Therapeutics, Inc.. The most heavily invested institutionals were:
HealthCor Management, L.P.: 0
ACT CAPITAL MANAGEMENT, LLC: 265,000
33.00% of Leap Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 265,000 shares in the last 24 months. This purchase volume represents approximately $765,850 in transactions.